Emiac Technologies IPO Date, Price Band per share, Allotment Details
Emiac Technologies IPO is an upcoming SME IPO opening on March 27, 2026 and closing on April 8, 2026. The company has fixed a price band of ₹93 to ₹98 per share, making it a mid-sized issue in the SME segment. Investors tracking Emiac Technologies IPO allotment status (April 9, 2026) and Emiac Technologies IPO listing date (April 13, 2026 on BSE SME) are closely watching this offering. With strong growth in revenue and profit, the initial public offering is gaining attention among investors looking for SME IPOs, IPO subscription updates, and listing gains in 2026. The allotment of shares of Emiac Technologies is determined based on demand and subscription levels across retail, HNI, and QIB categories.
Emiac Technologies IPO Highlights
| Particulars | Details |
|---|---|
| IPO Open Date | March 27, 2026 |
| IPO Close Date | April 8, 2026 |
| Issue Type | Book Build Issue |
| Face Value | ₹10 per share |
| Price Band | ₹93 to ₹98 per share |
| Issue Size | ₹31.75 Crores |
| Fresh Issue | ₹31.75 Crores |
| Listing Exchange | BSE SME |
| Allotment Date | April 9, 2026 |
| Listing Date | April 13, 2026 |
Emiac Technologies IPO Market Lot & Minimum Investment
The minimum market lot for Emiac Technologies IPO is 2,400 shares, requiring a retail investment of ₹2,35,200 at the upper price band.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2,400 | ₹2,35,200 |
| Retail Maximum | 2 | 2,400 | ₹2,35,200 |
| S-HNI Minimum | 3 | 3,600 | ₹3,52,800 |
| S-HNI Maximum | 8 | 9,600 | ₹9,40,800 |
| B-HNI Minimum | 9 | 10,800 | ₹10,58,400 |
The IPO allocation is divided into QIB 50%, Retail 35%, and HNI 15%, along with anchor investor participation.
Objectives of the Issue
The company plans to utilize IPO proceeds for multiple growth and operational purposes. Funds will be used for purchase of computers, laptops, software subscriptions, and cloud hosting (₹5.85 crores), along with working capital requirements (₹8.80 crores). Additionally, allocation is planned for hiring manpower (₹5.42 crores) and branding, advertisement, and marketing activities (₹3.90 crores).
Emiac Technologies IPO Dates & Allotment
Emiac Technologies IPO will open on March 27, 2026 and close on April 8, 2026. The allotment and listing schedule is as follows:
| Event | Date |
|---|---|
| IPO Open Date | March 27, 2026 |
| IPO Close Date | April 8, 2026 |
| Basis of Allotment | April 9, 2026 |
| Refunds | April 10, 2026 |
| Credit to Demat | April 10, 2026 |
| Listing Date | April 13, 2026 |
The IPO follows the standard SME listing timeline after allotment.
The Emiac Technologies IPO allotment status is expected to be finalized on April 9, 2026. Investors who applied for the IPO can check their allotment status online through the registrar’s website or their stock broker platform. Once the allotment is completed, successful applicants will receive shares in their Demat accounts by April 10, 2026, while refunds for unallotted applications will also be processed on the same day. The allotment is determined based on demand and subscription levels across retail, HNI, and QIB categories.
How to Apply for Emiac Technologies IPO
Investors can apply for the Emiac Technologies IPO through ASBA (Application Supported by Blocked Amount) via bank accounts or through UPI using stock broker platforms. The process is simple and follows standard IPO application steps in India.

Emiac Technologies IPO FAQ
Emiac Technologies IPO is an SME IPO aiming to raise ₹31.75 crores via fresh issue.
The IPO will open on March 27, 2026 and close on April 8, 2026.
The price band is ₹93 to ₹98 per share.
The allotment date is April 9, 2026.
Disclaimer: This article is for educational and informational purposes only and should not be considered investment advice. Investors should conduct their own research and read and understand all official company documents, including the company’s DRHP/RHP, with the assistance of a legally registered and certified financial professional before making any investment decisions. Any opinions or reviews expressed in this article are for informational purposes only and do not constitute a recommendation to buy or sell securities.
